| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.985 | 0.001 | 0.985 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.633 0.002 CID_71312701 | ||
| 0.858 | 0.003 | 0.923 | Cholesterol antagonist | 0.923 0.002 CID_71312701 | CID_71312701 | |
| 0.819 | 0.002 | 0.819 | Aromatase inhibitor | 0.712 0.002 CID_71312701 | ||
| 0.82 | 0.013 | 0.856 | Antiinflammatory | 0.856 0.009 CID_71312701 | CID_71312701 | |
| 0.793 | 0.012 | 0.793 | Caspase 9 stimulant | 0.262 0.239 CID_71312701 | ||
| 0.747 | 0.023 | 0.747 | Apoptosis agonist | 0.626 0.044 CID_71312701 | ||
| 0.688 | 0.005 | 0.688 | Hypoxia-inducible factor 1 alpha inhibitor | 0.408 0.028 CID_71312701 | ||
| 0.646 | 0.026 | 0.646 | Transcription factor NF kappa B inhibitor | 0.486 0.046 CID_71312701 | ||
| 0.546 | 0.004 | 0.546 | Interferon gamma antagonist | 0.264 0.026 CID_71312701 | ||
| 0.543 | 0.004 | 0.543 | Hedgehog signaling inhibitor | 0.16 0.02 CID_71312701 | ||
| 0.544 | 0.005 | 0.544 | Interleukin 2 agonist | 0.432 0.019 CID_71312701 | ||
| 0.536 | 0.004 | 0.536 | Androgen antagonist | 0.282 0.008 CID_71312701 | ||
| 0.524 | 0.006 | 0.524 | Anesthetic general | |||
| 0.536 | 0.024 | 0.536 | Immunosuppressant | 0.484 0.037 CID_71312701 | ||
| 0.515 | 0.003 | 0.515 | Cyclin-dependent kinase 8 inhibitor | 0.207 0.031 CID_71312701 | ||
| 0.511 | 0.019 | 0.511 | Apoptosis antagonist | 0.304 0.083 CID_71312701 | ||
| 0.493 | 0.002 | 0.578 | Cholesterol synthesis inhibitor | 0.578 0.001 CID_71312701 | CID_71312701 | |
| 0.506 | 0.048 | 0.506 | Cyclophilin D inhibitor | 0.423 0.079 CID_71312701 | ||
| 0.452 | 0.005 | 0.452 | Lipocortins synthesis antagonist | 0.375 0.011 CID_71312701 | ||
| 0.448 | 0.008 | 0.448 | Sodium/bile acid cotransporter inhibitor | 0.41 0.014 CID_71312701 | ||
| 0.433 | 0.015 | 0.433 | Interleukin agonist | |||
| 0.418 | 0.023 | 0.418 | Nitric oxide antagonist | 0.327 0.035 CID_71312701 | ||
| 0.398 | 0.008 | 0.398 | NOS3 expression enhancer | 0.272 0.022 CID_71312701 | ||
| 0.392 | 0.006 | 0.392 | Neurotrophic factor enhancer | |||
| 0.402 | 0.027 | 0.472 | Tumour necrosis factor alpha release inhibitor | 0.472 0.017 CID_71312701 | CID_71312701 | |
| 0.411 | 0.041 | 0.411 | Immunomodulator | 0.363 0.056 CID_71312701 | ||
| 0.388 | 0.024 | 0.388 | Psychostimulant | |||
| 0.401 | 0.044 | 0.401 | Caspase 3 stimulant | |||
| 0.344 | 0.002 | 0.344 | RNA-directed RNA polymerase stimulant | 0.223 0.003 CID_71312701 | ||
| 0.349 | 0.013 | 0.349 | Amylase inhibitor | |||
| 0.397 | 0.067 | 0.397 | Antiobesity | 0.359 0.083 CID_71312701 | ||
| 0.338 | 0.009 | 0.338 | DNA polymerase I inhibitor | 0.238 0.019 CID_71312701 | ||
| 0.348 | 0.019 | 0.348 | Hepatoprotectant | 0.34 0.021 CID_71312701 | ||
| 0.334 | 0.011 | 0.334 | Interleukin 6 antagonist | 0.155 0.081 CID_71312701 | ||
| 0.374 | 0.057 | 0.443 | Immunostimulant | 0.443 0.038 CID_71312701 | CID_71312701 | |
| 0.334 | 0.018 | 0.572 | Diuretic | 0.572 0.005 CID_71312701 | CID_71312701 | |
| 0.355 | 0.04 | 0.355 | DNA damaging | |||
| 0.324 | 0.011 | 0.324 | Growth factor agonist | 0.149 0.143 CID_71312701 | ||
| 0.309 | 0.005 | 0.374 | Estrogen agonist | 0.374 0.004 CID_71312701 | CID_71312701 | |
| 0.301 | 0.002 | 0.301 | Glycine receptor agonist | 0.148 0.007 CID_71312701 | ||
| 0.293 | 0.006 | 0.293 | Farnesoid X receptor antagonist | 0.193 0.024 CID_71312701 | ||
| 0.323 | 0.042 | 0.323 | Hypolipemic | 0.164 0.124 CID_71312701 | ||
| 0.323 | 0.048 | 0.323 | Cardiotonic | |||
| 0.328 | 0.066 | 0.328 | Calcium channel activator | |||
| 0.262 | 0.003 | 0.262 | Aldosterone antagonist | 0.062 0.018 CID_71312701 | ||
| 0.262 | 0.004 | 0.262 | Estrogen receptor alpha agonist | 0.111 0.007 CID_71312701 | ||
| 0.262 | 0.005 | 0.262 | ABCA1 expression enhancer | 0.154 0.016 CID_71312701 | ||
| 0.257 | 0.004 | 0.257 | 5-Alpha-reductase inhibitor | 0.07 0.014 CID_71312701 | ||
| 0.249 | 0.004 | 0.28 | Androgen agonist | 0.28 0.003 CID_71312701 | CID_71312701 | |
| 0.248 | 0.006 | 0.248 | Arachidonic acid antagonist | 0.2 0.033 CID_71312701 | ||
| 0.245 | 0.004 | 0.245 | Estrogen receptor beta agonist | 0.198 0.005 CID_71312701 | ||
| 0.242 | 0.005 | 0.242 | Pregnane X receptor agonist | 0.202 0.01 CID_71312701 | ||
| 0.298 | 0.067 | 0.298 | Aldehyde oxidase inhibitor | |||
| 0.294 | 0.064 | 0.345 | Antioxidant | 0.345 0.048 CID_71312701 | CID_71312701 | |
| 0.238 | 0.009 | 0.238 | Estrogen antagonist | 0.129 0.04 CID_71312701 | ||
| 0.226 | 0.002 | 0.267 | Anabolic | 0.267 0.002 CID_71312701 | CID_71312701 | |
| 0.234 | 0.015 | 0.234 | Neurotrophic factor | |||
| 0.224 | 0.011 | 0.224 | Acetylcholine nicotinic antagonist | |||
| 0.215 | 0.009 | 0.215 | AMP-activated protein kinase stimulant | |||
| 0.207 | 0.004 | 0.207 | Liver X receptor alpha agonist | |||
| 0.207 | 0.004 | 0.207 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.101 0.01 CID_71312701 | ||
| 0.204 | 0.003 | 0.204 | 5-Alpha-reductase 2 inhibitor | |||
| 0.247 | 0.05 | 0.361 | Platelet adhesion inhibitor | 0.361 0.017 CID_71312701 | CID_71312701 | |
| 0.2 | 0.003 | 0.2 | 5-Alpha-reductase 1 inhibitor | 0.017 0.012 CID_71312701 | ||
| 0.251 | 0.056 | 0.251 | EphB2 antagonist | |||
| 0.19 | 0.004 | 0.373 | Glycine receptor antagonist | 0.373 0.002 CID_71312701 | CID_71312701 | |
| 0.216 | 0.035 | 0.216 | Lipid peroxidase inhibitor | 0.166 0.058 CID_71312701 | ||
| 0.18 | 0.001 | 0.18 | Hedgehog signaling activator | 0.052 0.003 CID_71312701 | ||
| 0.249 | 0.07 | 0.576 | Angiogenesis stimulant | 0.576 0.008 CID_71312701 | CID_71312701 | |
| 0.214 | 0.036 | 0.214 | Melanin inhibitor | |||
| 0.21 | 0.038 | 0.21 | Phospholipase C inhibitor | 0.201 0.043 CID_71312701 | ||
| 0.173 | 0.006 | 0.173 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.178 | 0.012 | 0.178 | Estrogen receptor beta antagonist | 0.11 0.046 CID_71312701 | ||
| 0.207 | 0.044 | 0.207 | Antipruritic | |||
| 0.181 | 0.019 | 0.181 | Interleukin 8 antagonist | |||
| 0.165 | 0.009 | 0.468 | Acetylcholine release stimulant | 0.468 0.002 CID_71312701 | CID_71312701 | |
| 0.167 | 0.013 | 0.167 | Inducible nitric-oxide synthase inhibitor | 0.164 0.013 CID_71312701 | ||
| 0.276 | 0.126 | 0.276 | Toll-Like receptor 7 agonist | |||
| 0.155 | 0.007 | 0.155 | Bile acid receptor antagonist | 0.135 0.011 CID_71312701 | ||
| 0.239 | 0.095 | 0.239 | 5 Hydroxytryptamine release stimulant | |||
| 0.238 | 0.094 | 0.238 | Gastrin inhibitor | |||
| 0.146 | 0.006 | 0.146 | Progesterone antagonist | |||
| 0.178 | 0.039 | 0.178 | Cholinergic antagonist | |||
| 0.145 | 0.007 | 0.145 | Na+ K+ transporting ATPase inhibitor | 0.14 0.008 CID_71312701 | ||
| 0.139 | 0.004 | 0.139 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.267 | 0.133 | 0.267 | Toll-Like receptor agonist | |||
| 0.139 | 0.005 | 0.139 | Liver X receptor agonist | 0.067 0.014 CID_71312701 | ||
| 0.171 | 0.04 | 0.171 | Acetylcholine antagonist | |||
| 0.13 | 0.004 | 0.13 | Glucocorticoid antagonist | 0.088 0.005 CID_71312701 | ||
| 0.134 | 0.015 | 0.134 | Estrogen receptor alpha antagonist | |||
| 0.162 | 0.044 | 0.163 | Adenylate cyclase stimulant | 0.163 0.043 CID_71312701 | CID_71312701 | |
| 0.118 | 0.006 | 0.118 | Mineralocorticoid receptor antagonist | 0.064 0.017 CID_71312701 | ||
| 0.151 | 0.04 | 0.151 | Beta amyloid protein antagonist | |||
| 0.113 | 0.004 | 0.113 | Lipocortins synthesis agonist | 0.1 0.005 CID_71312701 | ||
| 0.203 | 0.095 | 0.331 | RNA-directed DNA polymerase inhibitor | 0.331 0.026 CID_71312701 | CID_71312701 | |
| 0.111 | 0.003 | 0.111 | Glucose-6-phosphate dehydrogenase inhibitor | 0.074 0.004 CID_71312701 | ||
| 0.166 | 0.059 | 0.166 | Insulin secretagoues | |||
| 0.143 | 0.041 | 0.143 | Microtubule formation inhibitor | |||
| 0.11 | 0.01 | 0.11 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.177 | 0.082 | 0.177 | P-glycoprotein inhibitor | |||
| 0.145 | 0.05 | 0.145 | Aldehyde dehydrogenase inhibitor | |||
| 0.104 | 0.01 | 0.104 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.206 | 0.114 | 0.206 | DNA synthesis inhibitor | |||
| 0.093 | 0.004 | 0.093 | Pregnane X receptor antagonist | |||
| 0.126 | 0.038 | 0.126 | Toll-Like receptor 4 antagonist | |||
| 0.111 | 0.025 | 0.111 | Keratolytic | |||
| 0.225 | 0.143 | 0.544 | Angiogenesis inhibitor | 0.544 0.023 CID_71312701 | CID_71312701 | |
| 0.084 | 0.005 | 0.084 | Liver X receptor beta agonist | |||
| 0.133 | 0.054 | 0.18 | Protein-tyrosine phosphatase 1B inhibitor | 0.18 0.035 CID_71312701 | CID_71312701 | |
| 0.146 | 0.071 | 0.146 | MAP kinase kinase 4 inhibitor | |||
| 0.108 | 0.033 | 0.108 | Transcription factor NF kappa B stimulant | |||
| 0.072 | 0.005 | 0.158 | Estrone sulfatase inhibitor | 0.158 0.003 CID_71312701 | CID_71312701 | |
| 0.172 | 0.105 | 0.172 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.07 | 0.004 | 0.07 | Progesterone agonist | 0.029 0.007 CID_71312701 | ||
| 0.071 | 0.007 | 0.071 | Farnesoid X receptor agonist | 0.047 0.016 CID_71312701 | ||
| 0.099 | 0.039 | 0.099 | GABA A receptor agonist | |||
| 0.061 | 0.004 | 0.061 | Glucocorticoid agonist | 0.045 0.005 CID_71312701 | ||
| 0.062 | 0.005 | 0.062 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.075 | 0.019 | 0.075 | Heme oxygenase stimulant | 0.059 0.049 CID_71312701 | ||
| 0.116 | 0.061 | 0.116 | GABA receptor agonist | |||
| 0.243 | 0.189 | 0.243 | Analgesic | |||
| 0.054 | 0.005 | 0.054 | Ceramide glucosyltransferase inhibitor | 0.041 0.015 CID_71312701 | ||
| 0.139 | 0.091 | 0.269 | Protein-tyrosine phosphatase inhibitor | 0.269 0.026 CID_71312701 | CID_71312701 | |
| 0.17 | 0.123 | 0.17 | Free radical scavenger | |||
| 0.117 | 0.071 | 0.117 | Alkylator | |||
| 0.236 | 0.191 | 0.402 | Antibacterial | 0.402 0.076 CID_71312701 | CID_71312701 | |
| 0.066 | 0.021 | 0.066 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.087 | 0.043 | 0.087 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.048 | 0.003 | 0.048 | Corticosteroid-like | 0.032 0.005 CID_71312701 | ||
| 0.068 | 0.027 | 0.068 | Botulinum neurotoxin type A inhibitor | |||
| 0.051 | 0.011 | 0.051 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.081 | 0.042 | 0.176 | CDC25A inhibitor | 0.176 0.009 CID_71312701 | CID_71312701 | |
| 0.054 | 0.016 | 0.054 | Parathyroid hormone antagonist | |||
| 0.1 | 0.064 | 0.1 | Bronchodilator | |||
| 0.046 | 0.01 | 0.046 | HMG CoA reductase inhibitor | |||
| 0.132 | 0.097 | 0.188 | Thrombolytic | 0.188 0.058 CID_71312701 | CID_71312701 | |
| 0.189 | 0.158 | 0.189 | MAP kinase kinase 3 inhibitor | |||
| 0.065 | 0.036 | 0.065 | Transcription factor AP-1 inhibitor | |||
| 0.06 | 0.031 | 0.098 | GABA receptor antagonist | 0.098 0.016 CID_71312701 | CID_71312701 | |
| 0.09 | 0.065 | 0.171 | Protein kinase C zeta inhibitor | 0.171 0.016 CID_71312701 | CID_71312701 | |
| 0.039 | 0.014 | 0.039 | Liver X receptor antagonist | |||
| 0.081 | 0.057 | 0.081 | Opioid kappa receptor antagonist | |||
| 0.17 | 0.146 | 0.17 | Peptidyltransferase inhibitor | |||
| 0.081 | 0.057 | 0.081 | Antineoplastic antibiotic | 0.079 0.058 CID_71312701 | ||
| 0.145 | 0.122 | 0.145 | Interleukin antagonist | |||
| 0.035 | 0.013 | 0.035 | Liver X receptor alpha antagonist | |||
| 0.024 | 0.001 | 0.024 | Transcortin receptor antagonist | |||
| 0.124 | 0.103 | 0.124 | Acetylcholine M1 receptor antagonist | |||
| 0.028 | 0.008 | 0.028 | Vitamin D receptor antagonist | |||
| 0.037 | 0.018 | 0.037 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.197 | 0.179 | 0.197 | Vasodilator, peripheral | |||
| 0.081 | 0.065 | 0.081 | Estrogen-related receptor beta agonist | |||
| 0.114 | 0.099 | 0.114 | Protein kinase stimulant | |||
| 0.11 | 0.095 | 0.11 | Bone formation stimulant | |||
| 0.086 | 0.072 | 0.086 | Prolactin inhibitor | |||
| 0.056 | 0.042 | 0.056 | Beta tubulin antagonist | |||
| 0.122 | 0.107 | 0.122 | CC chemokine 6 receptor antagonist | |||
| 0.099 | 0.085 | 0.099 | Adenylate cyclase inhibitor | |||
| 0.166 | 0.154 | 0.166 | Hypoglycemic | |||
| 0.06 | 0.049 | 0.06 | Nitric oxide donor | |||
| 0.162 | 0.152 | 0.162 | Spasmolytic | |||
| 0.044 | 0.035 | 0.044 | Microtubule stabilization | |||
| 0.014 | 0.006 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.011 0.01 CID_71312701 | ||
| 0.018 | 0.011 | 0.018 | Telomerase stimulant | |||
| 0.049 | 0.042 | 0.068 | GABA A receptor antagonist | 0.068 0.026 CID_71312701 | CID_71312701 | |
| 0.017 | 0.01 | 0.017 | Vitamin D receptor agonist | |||
| 0.041 | 0.035 | 0.041 | Geranyltranstransferase inhibitor | |||
| 0.078 | 0.073 | 0.078 | T cell inhibitor | |||
| 0.076 | 0.071 | 0.076 | Antineoplastic alkaloid | |||
| 0.022 | 0.017 | 0.022 | CYP24 inhibitor | |||
| 0.032 | 0.028 | 0.032 | Tubulin agonist | |||
| 0.186 | 0.182 | 0.186 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.109 | 0.106 | 0.109 | Interleukin 1 antagonist | |||
| 0.129 | 0.126 | 0.129 | Ca2+-transporting ATPase inhibitor | |||
| 0.027 | 0.026 | 0.027 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.047 | 0.054 | 0.187 | HIV-1 integrase (Strand Transfer) inhibitor | 0.187 0.01 CID_71312701 | CID_71312701 | |
| 0.113 | 0.13 | 0.296 | Hemostatic | 0.296 0.016 CID_71312701 | CID_71312701 | |
| 0.021 | 0.05 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.011 CID_71312701 | CID_71312701 | |
| 0.175 | 0.212 | 0.357 | Antithrombotic | 0.357 0.062 CID_71312701 | CID_71312701 | |
| 0.03 | 0.119 | 0.618 | NMDA 2B receptor antagonist | 0.618 0.003 CID_71312701 | CID_71312701 | |
| 0.03 | 0.136 | 0.075 | Heparanase inhibitor | 0.075 0.009 CID_71312701 | CID_71312701 | |
| 0.07 | 0.194 | 0.166 | Cell adhesion inhibitor | 0.166 0.037 CID_71312701 | CID_71312701 | |
| 0.02 | 0.155 | 0.229 | NMDA 2 receptor antagonist | 0.229 0.007 CID_71312701 | CID_71312701 | |
| 0.026 | 0.184 | 0.063 | Neuraminidase (influenza) inhibitor | 0.063 0.046 CID_71312701 | CID_71312701 | |
| 0.021 | 0.199 | 0.091 | HIV-1 integrase (3'-Processing) inhibitor | 0.091 0.029 CID_71312701 | CID_71312701 | |
| 0.026 | 0.228 | 0.113 | NMDA receptor antagonist | 0.113 0.039 CID_71312701 | CID_71312701 | |
| 0.016 | 0.233 | 0.245 | Selectin antagonist | 0.245 0.008 CID_71312701 | CID_71312701 | |
| 0.008 | 0.24 | 0.205 | NMDA 2D receptor antagonist | 0.205 0.003 CID_71312701 | CID_71312701 | |
| 0.02 | 0.374 | 0.161 | Glutamate receptor antagonist | 0.161 0.044 CID_71312701 | CID_71312701 | |
| 0.022 | 0.466 | 0.197 | Multidrug resistance-associated protein 1 inhibitor | 0.197 0.011 CID_71312701 | CID_71312701 | |
| 0.01 | 0.535 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 CID_71312701 | CID_71312701 | |
| 0.02 | 0.586 | 0.059 | Adenine nucleotide translocase inhibitor | 0.059 0.03 CID_71312701 | CID_71312701 | |
| 0.015 | 0.647 | 0.172 | Dual specificity phosphatase inhibitor | 0.172 0.073 CID_71312701 | CID_71312701 | |
| 0.009 | 0.67 | 0.296 | Cholecystokinin B agonist | 0.296 0.003 CID_71312701 | CID_71312701 | |
| 0.009 | 0.72 | 0.309 | Anticoagulant | 0.309 0.027 CID_71312701 | CID_71312701 | |
| 0.007 | 0.719 | 0.073 | Cell adhesion molecule inhibitor | 0.073 0.065 CID_71312701 | CID_71312701 | |
| 0.009 | 0.739 | 0.152 | Dual specificity phosphatase 3 inhibitor | 0.152 0.094 CID_71312701 | CID_71312701 | |
| 0.012 | 0.758 | 0.094 | Factor IXa inhibitor | 0.094 0.011 CID_71312701 | CID_71312701 | |
| 0.002 | 0.82 | 0.026 | Cholecystokinin B antagonist | 0.026 0.025 CID_71312701 | CID_71312701 | |
| 0.002 | 0.852 | 0.147 | Cholecystokinin agonist | 0.147 0.004 CID_71312701 | CID_71312701 | |
| 0.002 | 0.871 | 0.046 | Cholecystokinin A antagonist | 0.046 0.021 CID_71312701 | CID_71312701 | |
| 0.002 | 0.878 | 0.123 | Cholecystokinin A agonist | 0.123 0.004 CID_71312701 | CID_71312701 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |